Search

everythinglearnresearchcommunity

for

Search:↓

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Finasteride does not prevent bladder cancer.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Europe needs a clear system to watch over cosmetics for safety and to make sure product claims are true.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

DNA phenotyping helps predict physical traits from DNA with varying accuracy and requires careful ethical and legal handling.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Finasteride causes harmful organ changes in female mice.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.